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Abstract
Purpose: To evaluate the diagnostic performances of
3 Tesla multi-echo chemical shift-encoded gradient echo
magnetic resonance (MECSE-MR) imaging to simulta-
neously quantify liver steatosis and iron overload in a
wide spectrum of diffuse liver diseases having biopsy as
reference standard.
Methods: MECSE-MR-acquired images were used to
calculate fat fraction and iron content in a single breath-
hold in 109 adult patients. Proton density fat fraction
(PDFF) was prospectively estimated using complex-
based data reconstruction with multipeak fat modeling.
Water R2* was used to estimate iron content. Biopsy was
obtained in all cases, grading liver steatosis, siderosis,
inflammation, and fibrosis. Differences in PDFF and
R2* values across histopathological grades were ana-
lyzed, and ROC curves analyses evaluated the MR
diagnostic performance.
Results: Calculated fat fraction measurements showed
significant differences (p < 0.001) among steatosis grades,
beingunaffectedby thepresenceof inflammationor fibrosis
(p ‡ 0.05). A strong correlation was found between fat
fraction and steatosis grade (RS = 0.718, p < 0.001). Iron
deposits did not affect fat fraction quantitation (p ‡ 0.05),
except in cases with severe iron overload (grade 4). A strong
positive correlation was also observed between R2* mea-
surements and iron grades (RS = 0.704, p < 0.001). Cal-
culated R2* values were not different across grades of
steatosis, inflammation, and fibrosis (p ‡ 0.05).
Conclusion: A MECSE-MR sequence simultaneously
quantifies liver steatosis and siderosis, regardless coexist-
ing liver inflammation or fibrosis, with high accuracy in a
wide spectrumof diffuse liver disorders. This sequence can
be acquired within a single breath-hold and can be
implemented in the routine MR evaluation of the liver.
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associated parenchymal deposits. Although fat accumu-
lation is the histological hallmark of non-alcoholic fatty
liver disease (NAFLD), steatosis itself is a common
feature to many different conditions [1]. Hepatic iron
overload is mainly found in hemochromatosis and
transfusion-dependent anemia, although it is also com-
monly present in diverse chronic liver diseases [2].
Both fatty liver and iron overload are reversible
conditions, imposing an oxidative parenchymal stress
and interfering with each other in a cross-dependent
fashion. In patients with NAFLD and non-alcoholic
steatohepatitis, hepatic iron overload is frequently pre-
sent and associated with disease severity and ﬁbrosis
development [2]. Also, coexisting steatosis in patients
with iron overload acts as an important cofactor in the
development of fibrosis and cirrhosis [3].
Core biopsy is still considered the gold standard
technique to evaluate liver steatosis and iron overload [4,
5]. However, it is invasive, expensive, uncomfortable, and
prone to complications. Biopsy has also high sampling
inconsistency due to the spatial heterogeneous distribu-
tion of disease, the small size of the pathological speci-
men, and the large inter- and intra-observer variability
[4]. Most pathological evaluations are categorized in
descriptive subjective scores, without accurate quantita-
tive measurements. These limiting aspects have promoted
the development of in vivo imaging biomarkers able to
accurately quantify fat and iron.
MR imaging has been used to detect and quantify
liver steatosis and iron overload as independent entities.
In-phase (IP) and opposed-phase (OP) dual-echo chem-
ical shift T1-weighted gradient recalled echo imaging is
used in most institutions for intracellular fat identiﬁca-
tion. Liver steatosis is recognized as a decrease in hepatic
signal intensity on the OP images compared with the IP
images [1, 6]. In iron-loaded livers, a decrease in hepatic
signal intensity on the IP images compared with OP
images occurs and confounds the detection of fat. The
most widely used method for MR liver iron quantifica-
tion uses the signal intensity ratio between the liver and
the paraspinal muscles [7], but the coexistence of
steatosis increases the liver signal intensity and underes-
timates iron quantification.
More recently, several studies have demonstrated
the capability of multi-echo chemical shift-based en-
coded gradient echo MR (MECSE-MR) images for
accurate quantiﬁcation of liver steatosis, either using
phantoms [8–11], MR spectroscopy [12–16], or liver
biopsy [17–22] as reference standards. The MECSE-
MR results must be adjusted for those factors biasing
the voxel signal intensity of fat and water, such as T1
relaxation time, T2* decay effect, eddy currents, noise,
and fat spectral complexity. MECSE-MR sequences
independently estimate liver fat fraction and T2*,
allowing for the simultaneous assessment of liver iron
[10, 14, 20, 22, 23].
In order to be clinically implemented as reliable non-
invasive simultaneous quantitative imaging biomarker of
liver steatosis and iron overload, MECSE-MR metrics
must be validated in diverse clinical scenarios taking into
account confounder factors, such as inﬂammation and/
or ﬁbrosis.
Our objective was to evaluate the diagnostic perfor-
mances and confounding factors of 3 Tesla MECSE-MR
sequence to simultaneously quantify liver steatosis and
iron overload deposits, in a group of patients with dif-
ferent diffuse liver disorders, having histopathological
validation as reference gold standard.
Patients and methods
The Institutional Review Board approved this prospec-
tive study. Between February 2013 and January 2014,
116 consecutive adult patients with indication for liver
biopsy were recruited after written informed consent.
Seven patients were excluded due to claustrophobia
(n = 1), imaging artifacts (n = 3; skin tattoos, move-
ment, and radiofrequency zipper artifacts, respectively),
unsatisfactory biopsy sample (n = 1), and malignancy
within the sample (n = 2).
All patients had a percutaneous liver biopsy sample
acquired under ultrasonography guidance (16–18 G nee-
dles). The biopsied liver segment was documented for fur-
ther correlation with MR measurements. Patients with
focal liver lesions also had a targeted biopsy for the lesion.
Histopathological evaluation
Liver biopsy was the reference standard for grading
steatosis, iron deposits, inﬂammation, and ﬁbrosis. Two
pathologists (JRV, more than 15 years’ experience; FEC,
4th training year), blinded to the MR results, evaluated
in consensus the biopsy samples using hematoxylin–eo-
sin, Masson’s trichrome, and Perls’ Prussian stains.
Hepatic steatosis was scored as the proportion of
hepatocytes containing fat vesicles: no steatosis (grade 0,
less than 5%); mild steatosis (grade 1, 5–33%); moderate
steatosis (grade 2, 33–66%); and severe steatosis (grade 3,
more than 66%) [24]. Iron loading was graded consid-
ering the presence of granules within the hepatocytes as
grade 0 (iron granules absent or barely discernible in
high-power field 9400); grade 1 (granules easily con-
firmed at 9400 or barely discernible at 9250); grade 2
(granules resolved at 9100); grade 3 (granules resolved at
925); and grade 4 (visible at low power 910) [5]. The
Ishak modified scale was used for grading inflammation
(necro-inflammatory activity score range 0–18) and
fibrosis (F0–F6) [25]. The necro-inflammatory activity
score was grouped as no inflammation (score 0), mild
inflammation (score 1–6), moderate inflammation (score
7–12), and severe inflammation (score 13–18); Ishak
fibrosis staging was categorized into none or minimal
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fibrosis (F0–F1), moderate fibrosis (F2–F3), and marked
fibrosis/cirrhosis (F4–F6) [26].
MR imaging examination
Liver MR imaging (3T-TX Achieva, Philips Healthcare,
TheNetherlands) with a sixteen-channel phased-array coil
was performed within 30 days from liver biopsy. The 2D
MECSE-MR sequence used 12 echoes (TE’s = 0.99 to
8.69, short echo spacing = 0.7 ms; TR = 10 ms) with a
10 ﬂip angle [23] tominimize T1 bias. The whole liver was
covered under end-expiratory phase single breath-hold
acquisition (34 slices; voxel dimensions, 3 9 3 mm; slice
thickness, 7 mm; 0.3 mm gap; reconstruction voxel size,
2 9 2 mm; field of view, 375 9 302 mm; parallel imaging
effective acceleration factor, 1.8; bandwidth, 2433 hertz
per pixel). The total acquisition time ranged between 12
and15 s.Toavoid cross-talk between slices, excitationwas
independent for each slice.
Image analysis
Images were exported as raw data to quantify proton
density fat fraction (PDFF) and iron-related R2* mea-
surements using QLiver software (QUIBIM, Valencia,
Spain), which is based on least squares analysis by
Levenberg–Marquardt algorithm. The magnitude and
phase reconstructions allow two fitting procedures [23,
27]. The complex phase information estimates the reso-
nance peak of the larger component, either water or fat,
to generate frequency distribution maps. The algorithm
performs the fitting of a sinusoid of water and fat signals
modulated by exponential decays corresponding to R2*
of water and R2* of fat. The R2* water component was
only considered for the R2* measurements, the R2* fat
component being negligible. Spectral multipeak model-
ing of fat controlled the proton density of the multiple fat
peaks (75%, 420 Hz; 17%, 318 Hz; 8%, -94 Hz) [9]. The
pixel PDFF was the ratio between the normalized fat
proton density and the total (fat and water) proton
density (PDFF = PDF/[PDF + PDW]). The calculated
R2* was used to estimate iron content.
One radiologist (MF, 8 years’ experience on MR
imaging) reviewed the images blinded to histopathological
results, knowing the biopsied Couinaud segment. Median
PDFF (%) and iron-related water T2* shortening (R2*)
(s-1) were determined with regions of interest (ROI, 4 mm
radius) manually placed at the known biopsy segment
(Figs. 1 and 2), avoiding vessels and lesions.
Statistical analysis
As PDFFs and R2* values distributions were non-sym-
metrical, non-normally distributed variables were log-
transformed. Groups’ data are presented as mean and
standard deviation or median and interquartile range.
The Spearman correlation coefﬁcient was used to
calculate the degree of association between continuous
and/or ordinal variables. Differences of PDFF (log-
transformed) and R2* values between histological groups
of steatosis, iron, inflammation, and fibrosis were as-
sessed with one-way analysis of variance, with post hoc
Tukey HSD test, or by Kruskal–Wallis test with post hoc
Mann–Whitney test and Bonferroni correction.
The inﬂuence of different independent ordinal vari-
ables (histological grades of steatosis, siderosis, necro-
inﬂammatory activity, or ﬁbrosis) on PDFF and R2*
measurements was assessed by ANOVA tests. A Facto-
rial Analysis of Variance was performed to evaluate the
effect of the several histological variables on the PDFF
(log-transformed), all together, so that their joint effect
could be assessed (dependent variable: log-transformed
PDFF; factors: histological categorical vari-
ables—steatosis, iron deposits, inflammation, and fibro-
sis). Only two-way interactions were considered to avoid
empty cells. The iron grades were grouped for Factorial
Analysis of Variance as none (grade 0), mild to moderate
(grade 1–2), and marked iron overload (grade 3–4).
Receiver operating characteristic (ROC) analysis
evaluated measurements’ diagnostic performance. The
cut-off values that provided the best possible speciﬁcity
and sensitivity of MR imaging-derived PDFF and R2*
measurements according to the histological grades were
calculated.
SPSS (version 22; SPSS, IBM, Chicago, Ill) was used
for the analysis. For all tests, a two-tailed p value of less
than 0.05 was considered as statistically signiﬁcant.
Results
The ﬁnal study population (n = 109) included 61 men
and 48 women, with a mean (SD) age of 46.5 (13.5)
years, range of 19–77 years (Table 1). The clinical indi-
cations for liver core biopsies were liver graft dysfunction
(n = 32), persistent elevation of liver enzymes (n = 21),
chronic HCV infection (n = 14), hemochromatosis
(n = 8), alcoholic liver disease (n = 8), assessment of
liver parenchyma during investigation of focal liver le-
sion (n = 5), auto-immune hepatitis (n = 5), chronic
HBV infection (n = 5), toxic hepatitis (n = 4), NAFLD
(n = 4), and Wilson disease (n = 3). Mean time interval
between biopsy and MR examination was 2 days (range
0–25). Most patients (58%) underwent abdominal MR
imaging on the same day of liver biopsy.
Histopathological results
Biopsy samples were scored for hepatic steatosis and iron
as shown in Table 1. Forty-one patients had no steatosis
or iron overload, while 21 patients had both steatosis and
iron overload.
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The distribution of iron deposits was registered in 41
patients: 28 (68% of them) had iron only within hepa-
tocytes, 5 (12%) had reticuloendothelial (RES) iron, and
8 (20%) patients had iron both in hepatocytes and RES.
The Ishak modiﬁed classiﬁcation system was scored
in 95 patients (87%) for necro-inﬂammatory activity and
ﬁbrosis staging (Table 1). This classification could not be
established in 14 cases (12.8%) due to sample degrada-
tion, and were considered ‘‘missing values.’’
PDFF measurements
Mean (SD), median, interquartile range, and range for
MECSE-MR-derived PDFF were 5.5% (3.6%), 4.3%,
6.7%–3.5%, and 1.0%–20.0%, respectively.
PDFF (log-transformed) values showed signiﬁcant
differences (p < 0.001) among histological steatosis
grade groups (Fig. 3; Table 2), with a strong relationship
between PDFF and steatosis grades (RS = 0.718,
p < 0.001). Using Tukey HSD test, PDFF measure-
ments could differentiate between patients without
steatosis (grade 0) and mild steatosis (grade 1), and be-
tween moderate (grade 2) and severe (grade 3) steatosis
(p < 0.001) (Fig. 3).
Threshold PDFF values were generated for histo-
logical steatosis grading (Table 3). To diagnose the
presence of liver steatosis, distinguishing patients without
steatosis (grade 0, n = 74) from those with grade 1 or
greater (n = 35), PDFF had an area under the receiving
operating characteristic curve (AUC) of 0.930 (95%
confidence interval: 0.881–0.979; p < 0.001).
A PDFF threshold of 4.8% identiﬁed any grade of
steatosis (grade ‡ 1, 88.6% sensitivity and 85.1% speci-
ﬁcity). A PDFF threshold of 8.5% distinguished patients
with none or mild steatosis (grade £ 1) from patients
with moderate to severe steatosis (grade ‡ 2, 81.3%
Figure 1. A–E PDFF and
R2* values estimated in a
patient with severe steatosis
and iron overload (histologic
steatosis grade 3, iron grade
3). First echoes in Oppose
Phase (A) and In Phase
(B) and last echo In Phase
(C) as representative
images. Circular ROI was
placed in the first image, in
the same segment as liver
biopsy, estimating PDFF of
26% and R2* of 209 s-1.
PDFF (D) and R2*
(E) parametric maps
demonstrate the distribution
of fat and iron deposition in
the liver parenchyma.
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sensitivity and 96.8% speciﬁcity). A PDFF threshold of
12.9% identiﬁed patients with severe steatosis (grade 3,
100% sensitivity and 100% speciﬁcity).
Overall in this study, univariate analysis of PDFF
measurements (log-transformed) demonstrated that
PDFF measurements were unaffected by liver inﬂam-
mation (p = 0.738), fibrosis (p = 0.610), or iron de-
posits (p = 0.339). In the Factorial Analysis of Variance,
the only statistical significant main factor on log-trans-
formed PDFF measurements was steatosis (p < 0.001),
in the presence of all two-way interactions (histological
grades of steatosis, iron deposits, inflammation, and
fibrosis) (Table 4). Nevertheless, we have observed that
PDFF measurements overestimated liver steatosis in 3 of
5 patients with severe iron overload (iron histological
grade 4) (Fig. 2), corresponding to extremes for histo-
logical steatosis grade 0, in Fig. 3. Those patients had
R2* measurements ranging from 487 to 1299 s-1. Fur-
thermore, in a subset analysis excluding the 5 patients
with severe iron overload (histologic iron grade 4), a
higher correlation was found between PDFF and
steatosis grades (RS = 0.744, p < 0.001).
R2* measurements
The mean R2* values (s-1) were 86, median 42, IQR
66–35, range from 24 to 1299. A high significant corre-
lation was observed between R2* values and liver his-
tological iron grades (RS = 0.704, p < 0.001). Hepatic
R2* values increased with increasing iron grade
(p < 0.001) (Table 2; Fig. 4). Using Bonferroni post hoc
correction, the R2* measurements were significantly
different (p < 0.001) between levels of histological grade
of iron deposits, except between grades 2 and 3, and
grades 3 and 4. The R2* values were not significantly
different across different histological grades of steatosis
Figure 2. A–E PDFF and
R2* values estimated in a
patient with severe iron
overload (histologic grade
4), without steatosis. First
echoes in Oppose Phase
(A) and In Phase (B) and
last echo In Phase (C) as
representative images.
Circular ROI was placed in
the first image, in the same
segment as liver biopsy,
estimating R2* of 487 s-1.
PDFF was erroneously
estimated as 9%. PDFF
(D) and R2* (E) parametric
maps demonstrate the
distribution of fat and iron
deposition in the liver
parenchyma.
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(p = 0.947), inflammation (p = 0.530), and fibrosis
(p = 0.101). Unfortunately, a Factor Analysis of Vari-
ance for the R2* measurements with multiple factors
could not be performed due to the asymmetric distribu-
tion of the R2* data and heterogeneity of variances.
Liver R2* had an AUC of 0.848 (95% CI 0.776–0.919,
p < 0.001) for distinguishing patients with iron at liver
biopsy (grade ‡ 1) from those without, and an AUC of
0.976 (95% CI 0.949–1.000; p < 0.001) for distinguishing
patients with none or mild iron overload (grade £ 2)
from patients with moderate to severe iron overload
(grade ‡ 3) (Table 3). For the diagnosis of any grade of
siderosis, a R2* threshold of 42 s-1 provided a sensitivity
of 80.0% and a specificity of 75.9%. For differentiation
of histological iron grade 3 or greater from iron grade 2
or less, a R2* threshold of 91 s-1 had a sensitivity of
90.9% and a specificity of 94.9%.
Discussion
MECSE-MR imaging-derived fat and iron biomarkers
must be validated in wide normal and pathological liver
scenarios. In this prospective study, simultaneous quan-
tiﬁcation of liver PDFF and R2* was performed with
high accuracy, using a 3 T magnet, in a large group of
patients with diverse diffuse liver disorders, and taking
into account the main potential confounders such as liver
inflammation and fibrosis.
PDFF measurements had an excellent correlation
with histological steatosis grade, regardless iron content,
inﬂammation, or ﬁbrosis, and distinguishing between
dichotomized steatosis grades with great accuracy.
Studies presenting PDFF threshold values to diagnose
hepatic steatosis reported values ranging from 2.9% to
7.5% [18, 19, 21, 28, 29], similar to our 4.8% threshold.
Our thresholds differentiating steatosis grades are lower
than previously published [18, 19, 29], the differences
being related to different methodologies and patients’
cohorts. Multipeak reconstruction models rely on ‘‘a
priori’’ known fat spectra [9, 30]. In contrast to previous
studies [12–14, 18, 22, 29, 30], our study population had
predominantly low liver fat content, with the risk of
over-fitting the curve model. The three fat peaks model
(420, 318 and -94 Hz, at 3 T) was shown to provide
good results [9]. However, no specific choice of spectral
model seems to be significantly superior [31] for PDFF
measurements.
PDFF quantiﬁcation was not confounded by the
coexistence of inﬂammation or ﬁbrosis. Although there
were discrepancies regarding ﬁbrosis results [19, 21], most
authors have also reported no significant confounding
effects of fibrosis [18, 28, 29] or inflammation [28]. Iron
overload was neither a confounding factor for fat quan-
tification. Nevertheless, PDFF measurements overesti-
mated the steatosis grade in patients with high-grade
hemosiderosis (liver R2* ranging 487–1299 s-1). As ex-
pected, the correlation between PDFF and steatosis
grades improved when patients with severe iron overload
(histologic iron grade 4) were excluded. A previous report
Table 1. Clinical and histological characteristics of patient population
(N = 109 patients). Data in parenthesis are percentage
Characteristic Result
Sex
Man 61 (56)
Woman 48 (44)
Age (y)—mean ± SD, range 46.5 ± 13.5, 19–77
Man 48.0 ± 11.6, 20–76
Woman 44.5 ± 15.5, 19–77
Steatosis
0; <5% hepatocytes 74 (67.9)
1; >5–33% hepatocytes 19 (17.4)
2; >33–66% hepatocytes 11 (10.1)
3; >66% hepatocytes 5 (4.6)
Iron
0 (iron granules absent or barely discernible
in high-power field 9400)
55 (50.4)
1 (iron granules easily confirmed at 9400
or barely discernible at 9250)
27 24.8)
2 (iron granules resolved at 9100) 16 (14.7)
3 (iron granules resolved at 925) 6 (5.5)
4 (iron granules visible at low power 910) 5 (4.6)
Ishak necro-inflammatory activity
None (0) 7 (6.4)
Mild (1–6) 72 (66.1)
Moderate (7–12) 16 (14.7)
Severe (13–18) 0 (0)
N/A 14 (12.8)
Ishak fibrosis stage
None or minimal (F0–F1) 52 (47.7)
Moderate (F2-F3) 24 (22.0)
Marked fibrosis/cirrhosis (F4–F6) 19 (17.4)
N/A 14 (12.8)
N/A not applicable
Figure 3. Box and whisker plots of PDFF (%) measured in
all patients (n = 109), compared with histologic steatosis
grading. Extremes in grade 0 corresponded to patients with
hemochromatosis and histologic iron grade 4 (R2* measure-
ments ranging from 487 to 1299 s-1). Horizontal lines indicate
significant differences (p < 0.05) between groups, evaluated
by post hoc analysis.
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found no influence of iron overload [22], if T2* correction
was used. However, they did not have patients with R2*
over 200 s-1 [22]. As large iron content lead to extremely
low MR signal in gradient echo sequences, PDFF mea-
surements are corrupted by severe iron overload. There-
fore, PDFF quantitation is hampered if R2*
measurements are higher than 487 s-1. As thisR2* cut-off
value is based on our study population, it should be vali-
dated with larger populations and using the same quan-
titative approach. Phantom studies employing fat and iron
solutions will also help in defining this threshold value.
Regarding iron evaluation, R2* values were positively
correlated with histological iron grades without being
influenced by steatosis, inflammation, or fibrosis. Most
previous clinical studies addressing hepatic iron quan-
tification in diffuse liver diseases were performed with
1.5 T magnets [22, 32]. A recent study with 3 T magnet,
like in our series, also showed good estimation of iron
overload [33], however, without evaluation of possible
confounders. Our correlation (0.704) between R2* mea-
Table 2. PDFF and R2* results stratified by histologic grading of hepatic steatosis, iron deposits, necro-inflammatory activity and fibrosis
Histologic classification
(n. of patients)
PDFF (%)
Mean (SD), median
R2* (s-1)
Mean, median, IQR
Steatosis grade
(n = 109)
0 (64) 3.9 (1.4), 3.8 81, 38, 48–34
1 (15) 6.7 (2.1), 7.2 101, 44, 65–37
2 (11) 9.1 (2.5), 10.0 67, 58, 96–51
3 (5) 17.4 (3.0), 17.5 93, 67, 144–55
Iron grade
(n = 109)
0 (48) 5.2 (3.6), 4.2 36, 41–32
1 (24) 5.5 (2.6), 4.5 43, 53–39
2 (14) 4.7 (2.6), 4.4 75, 95–65
3 (5) 11.0 (7.7), 9.7 100, 128–91
4 (4) 7.8 (1.0), 7.4 779, 1069–578
ISHAK necro-inflammatory activity score
(n = 95)
0 (7) 7.5 (6.0), 6.3 70, 48, 72–43
1–6 (72) 5.7 (3.7), 4.4 94, 42, 69–36
7–12 (16) 4.6 (2.3), 4.0 42, 39, 46–29
ISHAK fibrosis score
(n = 95)
F0–F1 (52) 5.6 (3.7), 4.3 49, 40, 52–34
F2–F3 (24) 6.1 (4.4), 4.6 103, 49, 77–37
F4–F6 (19) 5.1 (2.3), 4.2 151, 45, 97–35
The histological classification of liver fibrosis and inflammation was performed in 95 of 109 patients. Histological evaluation of liver fibrosis and
inflammatory activity could not be evaluated in 14 cases (12.8% of patients) due to sample degradation
Table 3. PDFF and R2* thresholds compared with histologically determined liver fat and iron grades. Numbers in parentheses are 95% confidence
interval
Liver steatosis grade Number of patients PDFF thresholda AUCa Sensitivitya Specificitya Accuracya PPVa NPVa
0 vs. ‡1 35 4.8 0.930
(0.881–0.979)
88.6
(73.2–96.8)
85.1
(75.0–92.3)
86.2 73.8
(58.0–86.1)
94.0
(85.4–98.4)
£1 vs. ‡2 16 8.5 0.950
(0.901–0.998)
81.3
(54.4–96.0)
96.8
(90.0–99.3)
94.5 81.3
(54.4–96.0)
96.8
(90.9–99.3)
£2 vs. 3 5 12.9 1.000
(1.000–1.000)
100
(47.8–100)
100
(96.5–100)
100.0 100.0
(47.8–100)
100.0
(96.5–100)
Liver iron grade Number of patients R2* thresholdb AUC Sensitivity Specificitya Accuracya PPVa NPVa
0 vs. ‡1 55 42 0.848
(0.776–0.919)
80.0
(67.0–89.6)
75.9
(62.3–86.5)
78.0 77.2
(64.1–87.3)
78.8
(65.3–88.9)
£2 vs. ‡3 11 91 0.976
(0.949–1.000)
90.9
(58.7–99.8)
94.9
(88.5–98.3)
94.5 66.7
(38.4–88.2)
98.9
(94.2–100)
PPV, Positive predictive values; NPV, negative predictive values
a Data are shown in percentage
b Data are s-1
Figure 4. Box and whisker plots of R2* (log-transformed)
measured in all patients (n = 109) compared with histologic
iron grading. Horizontal lines indicate significant differences
(p < 0.05) between groups, evaluated by post hoc analysis.
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surements and histological iron grading is similar to
others (0.7–0.8) [32, 33]. This correlation might be
underestimated by coexistence of iron within hepatocytes
and RES in diffuse liver diseases [2] as R2* reflects liver
iron without discriminating its cellular location. Al-
though most of our patients with overload had iron
distributed only within hepatocytes, this might explain
some inaccuracies in patients with iron also within the
RES, not considered for the histological iron score.
Our study has some limitations. The study population
is from a real clinical scenario with a relatively small
number of patients having severe steatosis and severe
iron overload. The correlation is therefore biased to-
wards lower deposits. Nevertheless, our ﬁndings provide
meaningful information on the accuracies of PDFF and
R2* measurements and the absence of confounding ef-
fects when a MECSE approach is used for fat and iron
quantification in clinical practice. Although histological
grading was obtained by consensus, biopsy as reference
standard has large inter-observer and intra-observer
variability [4, 34]. In order to minimize the sampling bias,
our MR measurements were estimated from the biopsied
liver segment. The use of visual categorical scores for the
histological assessment of hepatic overload might explain
the absence of significant differences in PDFF measure-
ments between histologic steatosis grade 1 and 2, and it
could also have underestimated the correlation and
diagnostic accuracy of PDFF and R2* quantitative
measurements. Visual interpretation is observer-depen-
dent, not reproducible, and ignores the lipid composition
[35]. Computerized digital image analysis of liver tissue
will probably eliminate subjective imprecisions [35]. Im-
age processing tools for histological evaluation will,
therefore, probably improve the correlation between
histology and MR-derived PDFF quantification when
fat accumulation is mild or moderate. Furthermore,
more precise quantitative analytical essays for liver fat
and iron assessment will require a different liver sample
and they are usually not performed in clinical practice.
Unfortunately, digital and analytical quantitative meth-
ods were not available in our study.
PDFF measurements and thresholds may be affected
by the MECSE-MR sequence parameters and recon-
struction model. The TR was selected to minimize
acquisition time minimizing T1 influence. The combi-
nation of low flip angle and TR was also settled to
optimize signal-to-noise ratio (close to Ernst angle) and
contrast. Although the used flip angle might introduce
some measurement uncertainty due to residual T1 bias,
this bias was estimated to introduce a maximum devia-
tion of 5% for PDFF values around 50% [36]. Acquisi-
tion and postprocessing protocols might need to be
adjusted when simultaneous fat and iron quantification
is intended. For example, while a low flip angle is needed
to reduce T1 bias in PDFF quantification, a too low flip
angle sequence will result in decreased SNR, harming
iron quantification [6]. Our MECSE-MR sequence used
12 echoes, with a short echo spacing (0.7 ms). Although
the best curve fitting and number of echoes strategy have
yet to be defined and the number of echoes might be
smaller for PDFF quantification without decreasing
accuracy [37], our 12-echo approach improves R2*
quantification. Of importance, the first echo and the
echo spacing should be as short as possible to better
capture the signal decay in cases of severe iron overload
[38]. 3 T MR magnets have higher signal-to-noise ratio
and overall quality than 1.5 T units, being advantageous
for abdominal imaging. The R2* values given in this
study cannot be extrapolated to 1.5 T magnets. Higher
susceptibility artifacts on 3 T magnets [39] result in lower
thresholds for the maximum iron burden quantification
at this filed strength, due to T2*-shortening effect [2, 40].
Although the repeatability of our MECSE-MR sequence
was not evaluated, similar approaches have been found
to have extremely high intra- and inter-examination
PDFF estimation repeatability [41, 42]. Finally, we did
not compare our results of PDFF and R2* quantification
against other MRI methods or tools. However, it has
been demonstrated that estimation of hepatic PDFF is
reproducible across imaging methods, magnetic field
strengths, and different vendors [41, 42]. Iron-related
R2* quantification is also dependent on the magnetic
field strength and the quantitative MR protocol [6].
Nevertheless, hepatic R2* quantification seems to be
reproducible at 1.5 T and 3 T [43] and using fat-cor-
rected models might be more advantageous [6, 22, 44].
Further calibration studies with phantoms are necessary
to guarantee robustness, precision, and reproducibility of
the measurements.
In conclusion, 3 T MECSE T1- and T2*-corrected
MR sequence simultaneously identifies and quantifies
liver steatosis and siderosis, with high accuracy, and in a
wide spectrum of diffuse liver disorders, regardless of
coexisting liver inflammation or fibrosis. Because it can
be acquired within a single breath-hold, these parametric
images could be easily implemented in the routine clinical
MR evaluation of the liver.
Table 4. Factorial analysis of variance for PDFF measurements, con-
sidering PDFF (log transformed) as the dependent variable, and the
histological categorical variables as multiple factors (steatosis, iron
deposits, inflammation and fibrosis)
Factor p value
Steatosis grade <0.001
Iron deposits 0.339
Inflammation 0.738
Fibrosis 0.610
Interaction steatosis*fibrosis 0.669
Interaction steatosis*iron deposits 0.590
Interaction steatosis*inflammation 0.380
Interaction iron deposits*fibrosis 0.152
Interaction inflammation*fibrosis 0.950
Interaction iron deposits*inflammation 0.522
R2 = 0.746
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